Clinical Trials Directory

Trials / Unknown

UnknownNCT03103386

Effects of Fermented Rye Bran Products on Helicobacter Pylori (HP) Infection and Metabolic Risk Factors

Effects of Fermented Rye Bran Products on HP Infection and Metabolic Risk Factors

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
182 (actual)
Sponsor
Fudan University · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

The investigators hypothesize that long-term fermented high-fibre rye intake may reduce the Helicobacter pylori infection through dampening inflammation and thereby leading to lower adherence of the bacteria to surfaces.The investigators further hypothesize that that inflammation could be a potential causal link between HP infection and insulin resistance, a risk factor for type 2 diabetes and cardiovascular disease.

Detailed description

A randomized, double-blind, 12 week parallel dietary intervention study is conducted to evaluate the effects of the two novel food products containing fermented rye bran in normal weight and overweight men and women with prevalent HP infection. A follow-up is planned at week 24. The primary endpoint is severity of HP infection indicated by a breath test. Secondary endpoints include effects on chronic inflammation, insulin resistance, blood lipids, blood cholesterol,body weight, intestinal microbial clusters et al. The food products given to the treatment group will be a novel breakfast cereal product and a crispbread product containing fermented rye bran. The control product will be corresponding products based on refined wheat.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTintake of food product with a patented fermented rye branDuring the treatment period, participants will be provided 2 packages of puff(fermented rye bran)and 2 packages of crisp bread to be included in the daily diet. Participants are free to consume the product any time during the day to facilitate compliance.
DIETARY_SUPPLEMENTintake of food product with common refined wheatDuring the treatment period, participants will be provided 2 packages of puff (common refined wheat)and 2 packages of crisp bread to be included in the daily diet. Participants are free to consume the product any time during the day to facilitate compliance.

Timeline

Start date
2015-04-01
Primary completion
2015-09-01
Completion
2023-12-01
First posted
2017-04-06
Last updated
2023-06-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03103386. Inclusion in this directory is not an endorsement.